STOCK TITAN

Teradyne (TER) director Mercedes Johnson sells 167 shares in planned trade

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Teradyne, Inc. director Mercedes Johnson reported an open-market sale of 167 shares of common stock at $369.74 per share. The sale occurred on June 2, 2026 and was made pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2026. After this transaction, Johnson directly holds 6,864 Teradyne shares and indirectly holds 1,876 shares through The Mercedes Johnson Trust UAD 07/23/04, where she is trustee and sole beneficiary.

Positive

  • None.

Negative

  • None.
Insider JOHNSON MERCEDES
Role null
Sold 167 shs ($62K)
Type Security Shares Price Value
Sale Common Stock 167 $369.74 $62K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 6,864 shares (Direct, null); Common Stock — 1,876 shares (Indirect, By Trust)
Footnotes (1)
  1. The shares were sold pursuant to a sales plan adopted by the Reporting Person on March 4, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Shares held by The Mercedes Johnson Trust UAD 07/23/04 (the "Trust"), of which the Reporting Person is the trustee and sole beneficiary.
Shares sold 167 shares Open-market sale on June 2, 2026
Sale price $369.74 per share Price for Teradyne common stock sold
Direct holdings after sale 6,864 shares Common stock directly owned post-transaction
Indirect holdings 1,876 shares Held by The Mercedes Johnson Trust UAD 07/23/04
Rule 10b5-1 plan adoption date March 4, 2026 Plan governing June 2, 2026 share sale
Rule 10b5-1 regulatory
"intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
beneficiary financial
"of which the Reporting Person is the trustee and sole beneficiary"
indirect ownership financial
""ownership_type": "indirect""
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
JOHNSON MERCEDES

(Last)(First)(Middle)
C/O TERADYNE, INC.
600 RIVERPARK DRIVE

(Street)
NORTH READING MASSACHUSETTS 01864

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TERADYNE, INC [ TER ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/02/2026S(1)167D$369.746,864D
Common Stock1,876IBy Trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The shares were sold pursuant to a sales plan adopted by the Reporting Person on March 4, 2026 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
2. Shares held by The Mercedes Johnson Trust UAD 07/23/04 (the "Trust"), of which the Reporting Person is the trustee and sole beneficiary.
/s/ Ryan E. Driscoll, Attorney-in-Fact06/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Teradyne (TER) director Mercedes Johnson report?

Mercedes Johnson reported an open-market sale of 167 Teradyne common shares at $369.74 each on June 2, 2026. The filing also shows her remaining direct and indirect share holdings after this transaction.

How many Teradyne (TER) shares does Mercedes Johnson hold after the reported sale?

After selling 167 shares, Mercedes Johnson directly holds 6,864 Teradyne shares. She also indirectly holds 1,876 shares through The Mercedes Johnson Trust UAD 07/23/04, where she serves as trustee and sole beneficiary.

Was Mercedes Johnson’s Teradyne (TER) share sale made under a Rule 10b5-1 plan?

Yes. The filing states the 167 Teradyne shares were sold under a sales plan adopted on March 4, 2026, intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

What price did Mercedes Johnson receive for the Teradyne (TER) shares sold?

The reported sale price was $369.74 per Teradyne share for the 167 shares sold. This figure reflects the transaction price disclosed, not an average over multiple days or trades.

How are Mercedes Johnson’s indirect Teradyne (TER) holdings structured?

Her indirect holdings consist of 1,876 Teradyne shares held by The Mercedes Johnson Trust UAD 07/23/04. She is described as the trustee and sole beneficiary of this trust, which holds the shares on her behalf.